Inve
IN ⇄ US

Religare Enterprises share price & results

Religare Enterprises Limited· Financial Services

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Holding company for Care Health Insurance, Religare Broking, Religare Finvest and RHDFCL housing finance.

Company research is public. Sign in to keep your own companies, notes and cases.

Inve AI Signals on RELIGARE
Direct bridge to live research & tools watching Religare Enterprises Limited
Guidance Hit Rate
16 targets · 0% hit rate 0 achieved · 14 active →
Segment Shift
5 segments tracked See revenue & margin mix below →
Reverse DCF
Implied Growth Test priced-in growth in DCF tool →
Concall & Tone
Q1 FY27 analysed Read claims, qualifiers & Q&A →

Price & Snapshot

₹228.95 +2.15% · +₹4.81

Last close 5 Nov 2026 · NSE · INR · Source: Inve

Performance −12.8% 1Y

₹200₹220₹240₹260₹280Nov 25Dec 25Feb 26Mar 26May 26Jun 26Aug 26Sept 26Nov 26Q2 FY26 — 19 Nov 2025Q3 FY26 — 16 Feb 2026Q4 FY26 — 13 May 2026Q1 FY27 — 13 Aug 2026

1Y: ₹262.45 on 4 Nov 2025 → ₹228.95. High ₹278.36 (24 Jun 2026), low ₹201.11 (23 Mar 2026).

Previous close
₹224.14
Market cap
₹7.9k Cr
52-week range
₹201.11 – ₹278.36
One year
−12.76%
Price to earnings (TTM to Jun 2026)
157.86×
Return on equity (TTM to Jun 2026)
1.84%

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue26.0 ₹ crore+188.9% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin-2.1 %−2.9 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit-47.0 ₹ crore−687.5% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity1.84 %−2.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin21.38 %+1.1 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)19.01 %−3.6 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Business Mix

Where revenue comes from

5 operating segments · As of 31 Mar 2026

(d) Insurance 93.6% · ₹7,969.05 Cr
(b) Broking Related Activities 3.7% · ₹313.83 Cr
(a) Investment and Financing Activities 1.9% · ₹160.96 Cr +0.6pp mix
(c) E-Governance 0.7% · ₹62.87 Cr −0.4pp mix
(e) Unallocated 0.1% · ₹8.83 Cr

Explore full multi-period segment shift & margins →

Guidance

What management said, and what became of it

0 of 2 judged targets kept · 14 open · verdicts reflect calls analysed to Q1 FY27.

Religare Enterprises Limited management guidance track record on Inve: 16 targets tracked across analysed earnings calls (0 achieved, 2 missed, 14 open).

Watch execution in Growth & Demand (1 on track · 2 delayed/missed).

TargetOriginal wordingSaidLatest callVerdict
Growth Care Health Combined Ratioless than 100%
Call transcript, Q2 FY26 · 19 Nov 2025		Q2 FY26Q1 FY27:Promise remains missed. Superseded by a new two-year target set in Q4 FY26.
Call transcript, Q1 FY27 · 13 Aug 2026		Missed
Growth Demerger & RFL Listing Timeline15 to 18 months... culminate in the first quarter of FY '28
Call transcript, Q3 FY26 · 16 Feb 2026		Q3 FY26Q1 FY27:RBI has not acceded to the request for approval for the demerger scheme. Management is re-engaging with regulators, but the original timeline is now highly uncertain.
Call transcript, Q1 FY27 · 13 Aug 2026		At Risk
Growth Religare Housing Finance AUMfour digit kind of a franchise in few years
Call transcript, Q2 FY26 · 19 Nov 2025		Q2 FY26Q1 FY27:AUM grew marginally to 247 cr. The business remains in a rebuilding phase, with the long-term target still distant.
Call transcript, Q1 FY27 · 13 Aug 2026		On Track

Source: Inve Guidance Tracker for Religare Enterprises Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

2 of Religare Enterprises Limited's 16 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 13 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Supply chain

Cross-company call evidence

Named counterparties and similar headwinds disclosed on earnings calls.

Counterparties named by Religare Enterprises Limited

  • Religare Enterprises Limited → divests to → Religare Enterprises Limited (REL) and Religare Finvest Limited (RFL).

    Q4 FY26 · Announced · Neutral · Counterparty named; listed-company identity not verified.

    1. Proposed
    2. Announced
    3. Active
    4. Completed / ended

    Streamlining the group's structure for efficiencies, both from a capital and a shareholder perspective, to create 2 separately listed focused entities.

    “Under the proposed demerger, REL's lending, broking and ancillary financial services business will move to RFL, while REL will become a pure play health insurance holding company through its stake in Care Health Insurance business. Post the implementation of demerger, RFL shareholders shall receive 1 RFL share for every REL share held.”
    Evidence drawer

    Evidence type: Transcript excerpt

    “Under the proposed demerger, REL's lending, broking and ancillary financial services business will move to RFL, while REL will become a pure play health insurance holding company through its stake in Care Health Insurance business. Post the implementation of demerger, RFL shareholders shall receive 1 RFL share for every REL share held.”

    Source company: Religare Enterprises Limited · Counterparty: Religare Enterprises Limited (REL) and Religare Finvest Limited (RFL) · Call date: 2026-05-13 · Period: Q4 FY26 · Review status: Structured call extraction

  • Religare Enterprises Limited → divests to → Financial Services Business (from REL to RFL).

    Q3 FY26 · Announced · Neutral · Counterparty named; listed-company identity not verified.

    1. Proposed
    2. Announced
    3. Active
    4. Completed / ended

    To unlock shareholder value, create business clarity, and position resulting entities for sustained long-term growth.

    “On 14th Feb 2026 this year, the Boards of Religare Enterprises Limited and Religare Finvest Limited have approved the demerger of financial services and insurance businesses of the group into two focused and independent listed entities.”
    Evidence drawer

    Evidence type: Transcript excerpt

    “On 14th Feb 2026 this year, the Boards of Religare Enterprises Limited and Religare Finvest Limited have approved the demerger of financial services and insurance businesses of the group into two focused and independent listed entities.”

    Source company: Religare Enterprises Limited · Counterparty: Financial Services Business (from REL to RFL) · Call date: 2026-02-16 · Period: Q3 FY26 · Review status: Structured call extraction

Similar pressures reported by peers

Tailwind coverage is not available yet.

Similar commentary provides sector context; it does not establish a business relationship with Religare Enterprises Limited. Each comparison matches a headwind disclosed by Religare Enterprises Limited in the same calendar reporting quarter.

  • RBI has not acceded to the request for approval for the demerger scheme, requiring further…

    Topic: Regulatory compliance · Regulatory policy · Q1 FY27

    Religare Enterprises Limited reported: RBI has not acceded to the request for approval for the demerger scheme, requiring further engagement with regulators to understand the reasons and find a better alternative.

    Reporting period ended 2026-06-30

    37 other companies · Regulatory policy

    State Bank of India (SBIN) reported (period ended 2026-06-30): Forex revenues dropped to ₹500 crore due to war-related volatility and new RBI guidelines limiting net open position to $100 million.

    BSE Limited (BSE) reported (period ended 2026-06-30): The STT hike and RBI circular have impacted overall market futures and options volumes, and the full effect of the RBI circular (especially on bank guarantees) is still unfolding, making it difficult to assess the long-term impact on BSE.

    Tata Capital Limited (TATACAP) reported (period ended 2026-06-30): Revised RBI guidelines on gold loans, but management states they are compliant and have planned products accordingly, leading to a more organized market.

    Muthoot Finance Limited (MUTHOOTFIN) reported (period ended 2026-06-30): New regulatory guidelines (75%, 80%, 85% LTV across life of loans) require staff and customer re-training for new products and payment frequencies.

    Evidence drawer

    Evidence type: Summary paraphrase

    RBI has not acceded to the request for approval for the demerger scheme, requiring further engagement with regulators to understand the reasons and find a better alternative.

    Source company: Religare Enterprises Limited · Reporting period ended 2026-06-30 · Calendar quarter: Q1 FY27 · Distinct companies matched: 37

    Similar commentary provides sector context; it does not establish a business relationship.

Mentions over time

First observed: Q4 2025 · Latest observed: Q1 2026

Recorded disclosures by calendar reporting quarter
PeriodOther callsOwn calls
Q1 202601
Q4 202501

Counts reflect the calls covered here. No mention in a period does not establish that a relationship ended.

From available earnings-call summaries. Disclosures are management statements, not independently verified transactions.

Live Summary

RELIGARE ₹228.95 +2.15%
Guidance Verdict (16 tracked) 0 kept · 14 open· 2 missed
AI Call Brief · Q1 FY27

Religare Enterprises Limited Q1 FY27

Overview

Symbol
NSE:RELIGARE
Exchange
NSE
Currency
INR

What Religare Enterprises Limited does

Based on the company's own presentations, annual report and earnings calls.

Religare Enterprises is an RBI-registered Core Investment Company that holds controlling stakes across four financial-services verticals: Care Health Insurance (standalone health and travel insurance), Religare Broking (equity, currency and commodity broking plus depository and e-governance services), Religare Finvest (an NBFC focused on secured/unsecured MSME and retail lending), and Religare Housing Development Finance Corporation, RHDFCL (affordable housing loans for low-income, self-employed and first-time homebuyers in semi-urban and urban India). The group earns through insurance premiums and investment income at Care Health, brokerage plus interest income at Religare Broking, interest income on its loan book at Religare Finvest, and interest income on housing loans at RHDFCL. The Burman Group was designated as REL's promoter in 2025, and the boards of REL and Religare Finvest have approved a demerger under which REL would become a pure-play health-insurance holding company while the lending, broking and ancillary financial-services businesses move into Religare Finvest.

Segments

  • Insurance
  • Financial Services
Market position
2nd-largest standalone health insurer in India (Care Health Insurance)
Care Health branch network
277 branches
Care Health hospital tie-ups
22,040+ empanelled hospitals
Care Health distribution network locations
1,455+ network locations
Care Health insurance product range
44 products
Care Health distribution force
4,11,408 agents; 660 brokers; 239 corporate agents/bancassurance tie-ups
Founded 1984Headquarters New Delhi (registered office); Noida, Uttar Pradesh (corporate office) Company website

How the price took the results

Moved an average of ±2.6% across the last 4 priced result releases

Close before → close after
QuarterReleaseRevenue (₹ Cr) Net profit (₹ Cr)Rev YoYBefore → AfterReaction
Q1 FY2713 Aug 2626 -47+188.9%₹237.5 → ₹234.35−1.3%
Q4 FY2613 May 2621 96+110.0%₹222.3 → ₹227.44+2.3%
Q3 FY2616 Feb 2623 -77+130.0%₹244 → ₹231.28−5.2%
Q2 FY2619 Nov 256 46−73.9%₹262.4 → ₹258.85−1.4%

The move from the last close before each results date to the first close on or after it — the market's first read on the quarter alongside what was filed.

Your own record

Start an Inve Case for Religare Enterprises Limited

Free account: one company. Everything above stays public.

Write why you follow Religare Enterprises Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Financial Services companies

All Financial Services companies → · Financial Services earnings growth →

Quick Answers

Frequently asked questions on Religare Enterprises Limited

Compiled directly from RELIGARE's filed financial statements, earnings call transcripts, and ownership disclosures.

How did Religare Enterprises Limited (RELIGARE) perform in its latest reported quarter (Jun 2026)?

For the quarter ended Jun 2026, Religare Enterprises Limited reported revenue of ₹26 Cr, net profit of ₹-47 Cr, an operating margin of −2.1%. Diluted earnings per share stood at ₹-0.77.

How is Religare Enterprises Limited (RELIGARE) valued today, and what growth does the stock price imply?

Religare Enterprises Limited (RELIGARE) trades at ₹228.95, with a market capitalization of ₹7.9k Cr.

Who owns Religare Enterprises Limited (RELIGARE) — promoters, FIIs, DIIs, and mutual funds?

As of Sept 2026, Promoters hold 31.3%, FIIs hold 9.8%, DIIs hold 7.5%, Public shareholders hold 51.5%.

Learn to analyse Religare Enterprises Limited

Guides on how to read this kind of business and the numbers that matter.